Admission
The Call for Admission to the PhD Degree in Pharmaceutical Sciences is issued every year between April and June.
Undergraduates can also apply as long as they achieve the qualification by the date of enrollment in the course.
Possible reference for further information: Dr. Rosa De Vivo tel. 081-678745
Admission procedure
Evaluation of qualifications: admission of candidates is based on the evaluation of their Curriculum studiorum and on the qualifications presented at the time of application. In compiling their CVs, candidates must include the following information:
- date of graduation and grade of the master's degree
- detailed list of exams taken and relative marks
- any scholarships or research grants obtained (and similar qualifications)
- certificates of participation in post-graduate university courses
- certificates of participation in previous research groups
- certificates of participation in internships
- prizes or other qualifications that can be evaluated (eg second degrees, etc.)
The request for admission may possibly be supplemented by a summary of the degree thesis, the list of any scientific publications and a possible reference letter from a university professor.
Linguistic knowledge: Candidates must also demonstrate good knowledge of a foreign language. Knowledge of the foreign language will be assessed by reading and translating a text (identified during the test itself) into the foreign language chosen by the candidate among those determined by the announcement, and a brief conversation on the content of what has been read.
Oral exam: the oral exam is aimed at ensuring a suitable comparative evaluation of the candidates and at ascertaining the preparation and aptitude of the candidate for scientific research. The qualifications and topics covered by the oral exam must be relevant to the relevant scientific-disciplinary sectors of the PhD course; the interview will focus on a specific topic chosen by the candidate from the list that will be available in this page after the opening of the call.
List of selected topics for the 42nd cycle of the Doctoral Course in Pharmaceutical Science
|
Topic |
Title |
Tutor and cotutor |
|
Innovative Peptide-Based Materials for Biomedical and Biotechnological Applications
|
ACCARDO Antonella and DIAFERIA Carlo |
|
|
Design, Synthesis, and Characterization of Modified Nucleic Acids with Applications in Precision Medicine
|
BORBONE Nicola and TERRACCIANO Monica |
|
|
Rational Design and Structural Optimization of Keap1–Nrf2 PPI Inhibitors through an NMR-Guided Fragment-Based Deconstruction–Reconstruction Approach
|
BRANCACCIO Diego and IACCARINO Nunzia |
|
|
Development of Agents to Tackle Bacterial Resistance Under the One-Health Paradigm
|
BRINDISI Margherita and SUMMA Vincenzo |
|
|
Pharmacological Modulation of the Gut–Muscle Axis in Skeletal Muscle Pathophysiology: Role of Sulfur Metabolism
|
BUCCI Mariarosaria and VELLECCO Valentina |
|
| PEGylated Polymeric Nanoparticles for the Combined Delivery of siRNA and Chemotherapeutic Agents to Solid Tumors |
CONTE Claudia |
|
|
Development of Multi-Target Hybrids Combining Natural and Synthetic Bioactive Molecules for the Modulation of Neuroinflammation in Neurodegenerative Diseases
|
CORVINO Angela and SANTAGADA Vincenzo |
|
|
Microbiota–Tryptophan–Brain Axis in Neurodevelopmental and Stress-Related Disorders: Roleof Bioactive Lipids
|
CRISTIANO Claudia and RUSSO Roberto |
|
|
Development of Next-Generation Immune Checkpoint Modulators for Immuno-Oncology Using Artificial Intelligence and Advanced Computational Methods
|
DI LEVA Francesco Saverio and DONATI Greta |
|
|
Development and Validation of Innovative Active Ingredients for Cosmetic and Dermocosmetic Applications |
GRECO Giovanni and DI LORENZO Ritamaria |
|
|
Physicochemical Characterization of Bioactive Molecules from Food Waste and In Vitro ADME
Assessment
|
GRUMETTO Lucia and SANTAMARIA Rita |
|
| Artificial Intelligence and Generative Deep Learning for Nuclear Receptor Modulator Discovery |
LAVECCHIA Antonio and DE SIMONE Alfonso |
|
|
Exploring the effects of gut microbiota perturbation on DNA methylation program to control intestinal homeostasis and inflammation
|
LEMBO Francesca and CORETTI Lorena |
|
|
Repurposing Metallodrugs for Multifunctional Nanotherapeutic Intervention in Neurodegenerative Disorders
|
MARASCO Daniela and LA MANNA Sara |
|
|
Design and Development of Innovative Pharmaceutical Formulations for Controlled Drug Delivery to the Posterior Segment of the Eye
|
MAYOL Laura and BIONDI Marco |
|
|
Pharmacological Modulation of Mitochondrial Dysfunction in Cardiomyocytes by N-
Acylethanolamines (NAEs) and Their Derivatives: Development of Integrated Preclinical Models
Combining Multi-Omics Approaches and Biological Twins
|
MELI Rosaria and MATTACE RASO Giuseppina |
|
|
Marine-Inspired Lead Discovery for Multitarget Modulation of Metabolic and Inflammatory Disorders |
MENNA Marialuisa and IMPERATORE Concetta |
|
| Design and Synthesis of Peptide-Based Molecules Acting as Innovative Antimicrobial Agents |
MERLINO Francesco and GOMEZ MONTERREY Isabel Maria |
|
|
Advancing Target Discovery through Peptide-centric Local Stability Assay
(PELSA): Decoding the Interactome of Bioactive Compounds
|
MONTI Maria Chiara and ZAMPELLA Angela |
|
|
Development of Anti-miRNA Oligonucleotides Targeting Oncogenic Micro-RNAs in Glioblastoma |
PAGANO Bruno and GIANCOLA Concetta |
|
|
Nanoparticle-Mediated Immunogenic Reprogramming of the Peritoneal Tumor Microenvironment in Advanced Ovarian Cancer
|
QUAGLIA Fabiana and ROMANO Barbara |
|
|
|
Uncovering Novel Regulatory Mechanisms and Therapeutic Targets in Organ Fibrosis |
SORRENTINO Raffaella and D'EMMANUELE DI VILLABIANCA Roberta |
|
Development of Agents to Tackle Emerging Viral Infections with Pandemic
Potential as Defined by the WHO
|
SUMMA Vincenzo and BRINDISI Margherita |
|
| Development of Supramolecular Peptide Nanosystems for the Delivery of New Bioinorganic Drugs and Removal of Metals from the Environment |
TESAURO Diego and MORELLI Giancarlo |
|
|
Translational Development of Inhalable Nanoplatforms for Innovative Therapies of Severe Lung Diseases |
UNGARO Francesca and COSTABILE Gabriella |
|
| Targeting FPR2 con MR-39 per il controllo della progressione e del microambiente immunitario del glioblastoma |
VOLPICELLI Floriana and SPERANZA Luisa |
|
|
Role of Non-Canonical Nucleic Acid Structures in Disease Pathogenesis and Development of Innovative Gene Modulation Strategies
|
IACCARINO Nunzia and DI PORZIO Anna |
|
| Targeting KRAS Isoforms in Cancer |
DE SIMONE Alfonso |
|
|
|
Deciphering the Interaction between Innate Lymphoid Cells and Peritumoral Adipose Tissue |
ERCOLANO Giuseppe |
| Understanding and Designing Disordered Transcription Factors to Control Cell Differentiation Through Computational Approaches |
MERCADANTE Davide |
|
|
|
Strategies for RNA Delivery to the Brain |
NELE Valeria |
|
|
Tailored Immune Checkpoint Modulators Through Green Medicinal Chemistry for Immuno-Oncology |
RODRIQUEZ Manuela and LA PIETRA Valeria |